Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
Front Public Health. 2023 Sep 28;11:1243642. doi: 10.3389/fpubh.2023.1243642. eCollection 2023.
The provincial malaria diagnosis reference laboratories review and assess malaria cases diagnosed in health facilities for supporting the malaria elimination efforts and preventing re-transmission of imported malaria. The study aimed to evaluate the detection capability of malaria diagnosis in China from 2014 to 2021.
Data on malaria cases reported in the provincial-level administrative divisions (PLADs) of Anhui, Henan, Hubei, Guangxi, and Zhejiang from 2014 to 2021 were collected and analyzed.
In total, 5,770 malaria cases were reported from 2014 to 2021, and 99.05% (5,715/5,770) were submitted to the provincial malaria diagnosis reference laboratories. The median time between malaria cases being reported and the samples being received by reference laboratories was 6 days (Interquartile range, IQR:3-12 days) from 2017 to 2021. Diagnosis of 5,680 samples in the laboratory were confirmed by provincial reference laboratories, including 3,970 cases of , 414 of , 1,055 of , 158 of , 1 of , and 82 of mixed infections. species of 5,141 confirmed cases were consistent with the initial diagnosis, with a species accuracy rate of 90.53% (5,141/5,679). The accuracy of diagnosis in health facilities was higher than that of non-falciparum species. The inconsistency between microscopy and nested polymerase chain reaction (nPCR) results of confirmatory diagnosis was mainly in malaria-positive versus malaria-negative cases, as well as in mixed versus single infection cases.
The provincial malaria diagnosis reference laboratories have played an important role in ensuring the accuracy and reliability of diagnosis in health facilities. However, the results of this study imply that capacity training for the identification of species in health facilities is warranted.
省级疟疾诊断参考实验室对医疗机构诊断的疟疾病例进行审核和评估,为消除疟疾工作提供支持,并防止输入性疟疾的再传播。本研究旨在评估 2014 年至 2021 年中国疟疾诊断的检测能力。
收集并分析了 2014 年至 2021 年安徽、河南、湖北、广西和浙江省级行政区报告的疟疾病例数据。
2014 年至 2021 年共报告了 5770 例疟疾病例,其中 99.05%(5715/5770)提交给了省级疟疾诊断参考实验室。2017 年至 2021 年,实验室收到参考实验室的样本时间中位数为报告病例后 6 天(四分位距,IQR:3-12 天)。实验室对 5680 份样本进行了诊断,其中 3970 例确诊为 ,414 例为 ,1055 例为 ,158 例为 ,1 例为 ,82 例为混合感染。5141 例确诊病例的 种与初始诊断一致,种准确率为 90.53%(5141/5679)。医疗机构诊断的 准确性高于非恶性疟种。确认诊断中显微镜检查与巢式聚合酶链反应(nPCR)结果不一致主要是在疟疾阳性与疟疾阴性病例之间,以及混合感染与单一感染病例之间。
省级疟疾诊断参考实验室在确保医疗机构 诊断的准确性和可靠性方面发挥了重要作用。然而,本研究结果表明,有必要对医疗机构识别 种的能力进行培训。